Your browser doesn't support javascript.
loading
Zinc Finger Protein SALL4 Functions through an AT-Rich Motif to Regulate Gene Expression.
Kong, Nikki R; Bassal, Mahmoud A; Tan, Hong Kee; Kurland, Jesse V; Yong, Kol Jia; Young, John J; Yang, Yang; Li, Fudong; Lee, Jonathan D; Liu, Yue; Wu, Chan-Shuo; Stein, Alicia; Luo, Hongbo R; Silberstein, Leslie E; Bulyk, Martha L; Tenen, Daniel G; Chai, Li.
Afiliação
  • Kong NR; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Boston, MA 02115, USA.
  • Bassal MA; Harvard Stem Cell Institute, Boston, MA 02115, USA; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
  • Tan HK; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore; Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 117599, Singapore.
  • Kurland JV; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Yong KJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore; Department of Biochemistry, Yoon Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
  • Young JJ; Department of Biology, Simmons University, Boston, MA 02115, USA.
  • Yang Y; Hefei National Laboratory for Physical Sciences at Microscale, School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230026, China.
  • Li F; Hefei National Laboratory for Physical Sciences at Microscale, School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230026, China.
  • Lee JD; Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
  • Liu Y; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Boston, MA 02115, USA.
  • Wu CS; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
  • Stein A; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Luo HR; Joint Program in Transfusion Medicine, Department of Laboratory Medicne, Children's Hospital Boston, Boston, MA 02115, USA.
  • Silberstein LE; Joint Program in Transfusion Medicine, Department of Laboratory Medicne, Children's Hospital Boston, Boston, MA 02115, USA.
  • Bulyk ML; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Tenen DG; Harvard Stem Cell Institute, Boston, MA 02115, USA; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. Electronic address: daniel.tenen@nus.edu.sg.
  • Chai L; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Boston, MA 02115, USA. Electronic address: lchai@bwh.harvard.edu.
Cell Rep ; 34(1): 108574, 2021 01 05.
Article em En | MEDLINE | ID: mdl-33406418
ABSTRACT
The zinc finger transcription factor SALL4 is highly expressed in embryonic stem cells, downregulated in most adult tissues, but reactivated in many aggressive cancers. This unique expression pattern makes SALL4 an attractive therapeutic target. However, whether SALL4 binds DNA directly to regulate gene expression is unclear, and many of its targets in cancer cells remain elusive. Here, through an unbiased screen of protein binding microarray (PBM) and cleavage under targets and release using nuclease (CUT&RUN) experiments, we identify and validate the DNA binding domain of SALL4 and its consensus binding sequence. Combined with RNA sequencing (RNA-seq) analyses after SALL4 knockdown, we discover hundreds of new SALL4 target genes that it directly regulates in aggressive liver cancer cells, including genes encoding a family of histone 3 lysine 9-specific demethylases (KDMs). Taken together, these results elucidate the mechanism of SALL4 DNA binding and reveal pathways and molecules to target in SALL4-dependent tumors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Regulação Neoplásica da Expressão Gênica / Dedos de Zinco / Carcinoma Hepatocelular / Proteínas de Ligação a DNA / Células-Tronco Embrionárias / Histona Desmetilases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Regulação Neoplásica da Expressão Gênica / Dedos de Zinco / Carcinoma Hepatocelular / Proteínas de Ligação a DNA / Células-Tronco Embrionárias / Histona Desmetilases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos